tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
KYMR is currently covered by 9 analysts with an average price target of $68.09. This is a potential upside of $11.8 (20.96%) from yesterday's end of day stock price of $56.29.
Kymera Therapeutics's activity chart (see below) currently has 87 price targets and 55 ratings on display. The stock rating distribution of KYMR is 83.33% BUY and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 76.4% with an average time for these price targets to be met of 238.33 days.
Highest price target for KYMR is $70, Lowest price target is $38, average price target is $54.89.
Most recent stock forecast was given by GEOFF MEACHAM from BAML on 26-Jun-2025. First documented stock forecast 14-Sep-2020.
Currently out of the existing stock ratings of KYMR, 10 are a BUY (83.33%), 2 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$54
$-3.9 (-6.74%)
$43
3 months 12 days ago
(26-Jun-2025)
4/5 (80%)
$9.88 (22.39%)
108
Buy
$53
$-4.9 (-8.46%)
$38
3 months 13 days ago
(25-Jun-2025)
3/4 (75%)
$7.29 (15.95%)
123
Buy
$64
$6.1 (10.54%)
$59
3 months 14 days ago
(24-Jun-2025)
1/3 (33.33%)
$17.53 (37.72%)
578
Buy
$70
$12.1 (20.90%)
$80
4 months 26 days ago
(12-May-2025)
0/2 (0%)
$38.86 (124.79%)
Hold
$38
$-19.9 (-34.37%)
$41
4 months 27 days ago
(11-May-2025)
6/7 (85.71%)
$5.83 (18.12%)
186
What is KYMR (Kymera Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KYMR (Kymera Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?
Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?
Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?
